Komori
Takamisawa Cybernetics Company (6424) · RiskRestated

Lengthy new-product development and the emergence of substitute technologies

First written in FY2016. 23 of 24 entries say "Restated". Latest entry: FY2025.

24entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20252016: 320162017: 420172018: 220182019: 320192020: 220202021: 320212022: 220222023: 220232024: 220242025: 12025
Same theme, other companies
Risk of Delayed New Product Launches Due to R&D DelaysA theme 72 companies write about · 72 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 3 of 22 companies on the "Worse" side.

44 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 72 companies compared. The sentences above are computed from all 72.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「ただし、開発期間の長期化、代替技術・商品の出現等の要因により、最適な時期に、最適な製品を市場に供給できない可能性があります。この場合、業績及び成長見通しに影響が及ぶことが考えられます。」

    新製品開発の長期化及び代替技術・商品の出現による製品供給・成長見通しへの影響リスクを継続記載している。
  2. FY2025-H1RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  3. FY2024-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、新規発生・重要な変更はないと記載している。
  4. FY2024-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、新規発生・重要な変更はないと記載している。
  5. FY2024-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、新規発生・重要な変更はないと記載している。
  6. FY2023-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、新規発生・重要な変更はないと記載している。
  7. FY2022-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  8. FY2022-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  9. FY2021RestatedAnnual report

    「ただし、開発期間の長期化、代替技術・商品の出現等の要因により、最適な時期に、最適な製品を市場に供給できない可能性があります。この場合、業績及び成長見通しに影響が及ぶことが考えられます。」

    開発長期化や代替技術・商品の出現により、適時・適切な製品供給や成長見通しに影響するリスクを継続記載している。
  10. FY2021-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  11. FY2021-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。特段の数値化や発生事実の記載はない。
  12. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  13. FY2020-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  14. FY2020-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  15. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  16. FY2019-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  17. FY2018-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  18. FY2018-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  19. FY2018-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  20. FY2017RestatedAnnual report

    「ただし、開発期間の長期化、代替技術・商品の出現等の要因により、最適な時期に、最適な製品を市場に供給できない可能性があります。この場合、業績及び成長見通しに影響が及ぶことが考えられます。」

    開発長期化や代替技術・商品の出現により、適時・適切な製品供給や成長見通しに影響するリスクを継続記載している。
  21. FY2017-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  22. FY2017-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  23. FY2017-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    前年度記載の新製品開発の長期化・代替技術出現リスクについて、重要な変更がないとされた。
  24. FY2016First statedAnnual report

    「ただし、開発期間の長期化、代替技術・商品の出現等の要因により、最適な時期に、最適な製品を市場に供給できない可能性があります。」

    開発期間の長期化や代替技術・商品の出現により、適時・適切な製品供給ができない可能性。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Takamisawa Cybernetics Company yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.